A novel decision model to predict the impact of weight management interventions: The Core Obesity Model

Models are needed to quantify the economic implications of obesity in relation to health outcomes and health‐related quality of life. This report presents the structure of the Core Obesity Model (COM) and compare its predictions with the UK clinical practice data.

• Publication year

  2021

• Venue

  Obesity Science & Practice

• Publication date

  2021-03-09

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1002/osp4.495PMID 34123394PMCID 8170577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity: Health and Economic Consequences of an Impending Global Challenge

  2020cited by this paper
• Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM

  2020cited by this paper
• External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions

  2020influential reference
• Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions”

  2020cited by this paper
• Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses

  2019cited by this paper
• Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK

  2018cited by this paper
• BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian Randomization

  2018cited by this paper
• Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

  2018cited by this paper
• Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

  2017cited by this paper
• Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review

  2017cited by this paper
• Is body mass index associated with lowest mortality increasing over time?

  2017cited by this paper
• Obesity: Risk factors, complications, and strategies for sustainable long‐term weight management

  2017cited by this paper
• Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study

  2017cited by this paper
• Health Effects of Overweight and Obesity in 195 Countries over 25 Years.

  2017cited by this paper
• Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

  2016cited by this paper
• Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis

  2016cited by this paper
• BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants

  2016cited by this paper
• Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation.

  2016cited by this paper
• Economic burden of underweight and overweight among adults in the Asia‐Pacific region: a systematic review

  2016cited by this paper
• Body weight gain and risk of colorectal cancer: a systematic review and meta‐analysis of observational studies

  2015cited by this paper
• Obesity and inequities. Guidance for addressing inequities in overweight and obesity

  2014cited by this paper
• The cost‐effectiveness of the LighterLife weight management programme as an intervention for obesity in England

  2014cited by this paper
• The effect of age on the shape of the BMI–mortality relation and BMI associated with minimum all-cause mortality in a large Austrian cohort

  2014cited by this paper
• Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study

  2014cited by this paper
• Stroke: Highlights of Selected Articles

  2013cited by this paper
• UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82

  2013influential reference
• Obesity as a Major Risk Factor for Cancer

  2013cited by this paper
• Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.

  2012influential reference
• Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study

  2012cited by this paper
• EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation.

  2012cited by this paper
• Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

  2012cited by this paper
• What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.

  2012cited by this paper
• Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance

  2012cited by this paper
• Model Transparency and Validation

  2012cited by this paper
• Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty

  2011influential reference
• Health and economic burden of the projected obesity trends in the USA and the UK.

  2011cited by this paper
• Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006.

  2010cited by this paper
• Risk Prediction of Cardiovascular Disease in Type 2 Diabetes

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

  2008cited by this paper
• Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

  2007cited by this paper
• Body mass and colorectal cancer risk in the NIH-AARP cohort.

  2007cited by this paper
• Adiposity, adult weight change, and postmenopausal breast cancer risk.

  2006cited by this paper
• Orlistat for the treatment of obesity: cost utility model

  2005cited by this paper
• Relationships between body mass indices and surgical replacements of knee and hip joints.

  2003cited by this paper
• Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study.

  2002cited by this paper
• Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.

  2002cited by this paper
• Obesity : Preventing and managing the global epidemic

  2000cited by this paper
• Primary and subsequent coronary risk appraisal: new results from the Framingham study.

  2000influential reference
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

  2000cited by this paper

• Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT Trial

  2026influential citation
• Obesity/overweight prevalence and economic burdens by bariatric surgery, metabolic syndrome, and related comorbidity in 2013-2019: a nationwide descriptive analysis.

  2025cites this paper
• Critical Analysis of Markov Modeling for the Economic Evaluation of Obesity Interventions: A Systematic Review

  2025cites this paper
• The cost-effectiveness of subcutaneous semaglutide 2.4 mg in the management of people living with obesity and prediabetes in England

  2025influential citation
• External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness

  2025cites this paper
• Obesity: Genetic Insights, Therapeutic Strategies, Pharmacoeconomic Impact, and Psychosocial Dimensions

  2025cites this paper
• Changes in Body Weight Perception, Lifestyle Habits, and Health Awareness in Croatia: A Comparative Population Survey (2022–2024)

  2025cites this paper
• Assessing the health and economic burden of obesity-related complications in East-Asian populations: implementation of risk equations in the Core Obesity Model for Japan and model validation

  2024cites this paper
• Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective

  2024cites this paper
• Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal

  2024cites this paper
• Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature

  2023cites this paper
• Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom

  2023cites this paper
• Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective.

  2023cites this paper
• How Unawareness of Weight Excess Can Increase Cardiovascular Risk?

  2022cites this paper